Modular Medical shares jump 10.93% intraday after validating Pivot controller line for Q1 2026 launch.

Modular Medical (Nasdaq: MODD) surged 10.93% intraday after announcing the successful validation of its Pivot controller line, a critical manufacturing milestone for its Q1 2026 market launch. The validation confirms readiness for high-volume production of its tubeless, removable 3-milliliter patch pump, targeting the $3 billion market for adult "almost-pumpers" seeking affordable, user-friendly insulin delivery. The company emphasized its scalable platform positions it to capture significant market share, with CEO Jeb Besser highlighting efficient production scalability as a key differentiator. The news, reported across six identical press releases, underscores reduced manufacturing risk ahead of commercialization, aligning with the stock's sharp intraday gains.